| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,190 |
5,747 |
$326K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,321 |
1,252 |
$109K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
434 |
419 |
$35K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
565 |
527 |
$23K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
510 |
483 |
$9K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,071 |
1,032 |
$9K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
87 |
85 |
$6K |
| 3074F |
|
3,459 |
3,330 |
$5K |
| 87428 |
|
157 |
146 |
$5K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
19 |
17 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
79 |
63 |
$1K |
| 96127 |
|
260 |
244 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
43 |
41 |
$898.69 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
793 |
745 |
$692.70 |
| 81002 |
|
220 |
209 |
$345.22 |
| 1160F |
|
4,567 |
4,383 |
$309.00 |
| 3078F |
|
2,587 |
2,497 |
$153.00 |
| 1125F |
|
2,174 |
2,090 |
$126.00 |
| 3075F |
|
66 |
66 |
$100.00 |
| 1126F |
|
1,496 |
1,434 |
$99.00 |
| 3077F |
|
92 |
88 |
$47.00 |
| 3079F |
|
905 |
866 |
$30.00 |
| 3080F |
|
39 |
39 |
$15.00 |
| 3008F |
|
2,558 |
2,448 |
$0.00 |
| 1157F |
|
710 |
677 |
$0.00 |
| 1170F |
|
1,155 |
1,092 |
$0.00 |
| 1111F |
|
1,123 |
1,073 |
$0.00 |
| 4010F |
|
41 |
38 |
$0.00 |
| 3288F |
|
5,119 |
4,912 |
$0.00 |
| 3725F |
|
3,845 |
3,667 |
$0.00 |
| 1159F |
|
2,175 |
2,082 |
$0.00 |
| G0382 |
Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
174 |
149 |
$0.00 |